The Success of Failure: Tashia Bradley at TEDxColbyCollege Dr. Bradley is in her second year as Colby's Dean of Multicultural Affairs and director of the Pugh Center. Before that she served 6 years as director of the... By: TEDxTalks … Continue reading →

Win with people: Steven Opgenorth at TEDxColbyCollege Steve Opgenorth is in his first year as offensive coordinator and recruiting coordinator for the Colby College football program in the 2012 season. Opgenorth... By: TEDxTalks … Continue reading →

Innovation By: brainsick stuck … Continue reading →

Quadriplegic Lighting A Cigarette "Confessions Of A Quad" Me explaining how to light a cigarette with no finger movement. By: Dan Larsen … Continue reading →

My Story on How I was Shot Paralyzed by a Gang Banger (Another Senseless Shooting) Part 1 my life Changed due to the senseless act of someone choosing to Aim Fire a gun, I along with two other woman we're shot we didn't know each other but, we all... By: UniqueShawnique … Continue reading →

WASHINGTON (AP) -- A federal appeals court has sided with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used to process adult stem cells. Cytori Therapeutics Inc. makes the Celution and StemSource devices which separate adult stem cells from fat tissue using a combination of spinning motions and chemical reactions. The company is studying the technology for a variety of medical uses, including breast reconstruction, burn healing and treating damaged heart tissue. The technology has even been adopted by some plastic surgeons, who claim adult stem cells can be injected into the face, breast and other areas to create a younger look. Medical devices cannot be marketed in the U.S. without prior approval by the FDA. Cytori asked the FDA in 2011 to approve the Celution and StemSource devices using a fast-track pathway reserved for devices that are similar to products already on the market. Cytori argued that its technology is similar to that used to process cells from blood and bone marrow. The FDA rejected that argument and told the company it would need to apply through a more … Continue reading →

Cytori Therapeutics Inc. (CYTX), a biotechnology company developing experimental burn treatment therapies, lost a U.S. appeals court bid to overturn the Food and Drug Administrations initial rejection of two medical devices that use fat as a source of stem-cell therapy. The U.S. Court of Appeals in Washington upheld the FDAs decision that two devices submitted by Cytori for approval required more extensive testing before they could be released safely on the market. The devices, called Celution and StemSource, arent substantially equivalent to currently marketed devices, which rely on blood or marrow cells, U.S. Circuit Judge Brett Kavanaugh wrote today in the 12-page opinion. The FDA reasonably concluded and reasonably explained that the Celution and StemSource did not meet either the intended use requirement or the technological characteristics requirement for a substantial equivalence determination, Kavanaugh said in a ruling joined by circuit judges Janice Rogers Brown and David Sentelle. In order to win approval for new medical devices through a more streamlined premarket notification process, the devices have to be similar to others already on the market and have similar uses, Kavanaugh said. Cytori shares fell as much as 3 percent on the news before recovering to $2.77 in New York … Continue reading →

In the past 20 years, stem cell research has been thrust into the medical spotlight as celebrities like Michael J. Fox and Christopher Reeve have advocated for it. Also, numerous studies have shown stem cell therapies have successfully treated a plethora of diseases. And now, with the release of The Healing Cell: How the Greatest Revolution in Medical History Is Changing Your Life, the Catholic Church has given its stamp of approval on adult stem cell research by discussing the many ways these therapies work for the greater good. In fact, Pope Emeritus Benedict XVI wrote the books introduction, which was co-authored by Dr. Robin Smith and Monsignor Tomasz Trafny, along with Max Gomez. Stem cell therapy isnt anything new. Using bone marrow transplants to treat leukemia, which started more than 40 years ago, is essentially the same procedure. Through this process, doctors extract stem cells from the bone marrow and transplant them into the body to replace damaged cells caused by blood and bone marrow cancers. Sometimes cancer patients use autologous cells cells harvested from their own body and sometimes they use donated cells from another persons bone marrow. Ethical concerns Smith said when celebrities began speaking out on … Continue reading →